Impact of nutrition since early life on cardiovascular prevention. by Guardamagna, Ornella et al.
ITALIAN JOURNAL 
OF PEDIATRICS
Guardamagna et al. Italian Journal of Pediatrics 2012, 38:73
http://www.ijponline.net/content/38/1/73REVIEW Open AccessImpact of nutrition since early life on
cardiovascular prevention
Ornella Guardamagna1*, Francesca Abello1, Paola Cagliero1 and Lorenzo Lughetti2Abstract
The cardiovascular disease represents the leading cause of morbidity and mortality in Western countries and it is
related to the atherosclerotic process. Cardiovascular disease risk factors, such as dyslipidemia, hypertension, insulin
resistance, obesity, accelerate the atherosclerotic process which begins in childhood and progresses throughout the
life span. The cardiovascular disease risk factor detection and management through prevention delays the
atherosclerotic progression towards clinical cardiovascular disease. Dietary habits, from prenatal nutrition,
breastfeeding, complementary feeding to childhood and adolescence nutrition play a basic role for this topic.
The metabolic and neuroendocrine environment of the fetus is fundamental in the body’s “metabolic
programming”. Further several studies have demonstrated the beneficial effects of breastfeeding on cardiovascular
risk factors reduction. Moreover the introduction of complementary foods represents another important step, with
particular regard to protein intake. An adequate distribution between macronutrients (lipids, proteins and
carbohydrates) is required for correct growth development from infancy throughout adolescence and for
prevention of several cardiovascular disease risk determinants in adulthood.
The purpose of this review is to examine the impact of nutrition since early life on disease.
La malattia cardiovascolare rappresenta la principale causa di morbilità e mortalità dei paesi occidentali ed è
correlata a degenerazione vascolare aterosclerotica. I fattori di rischio cardiovascolari quali dislipidemia, ipertensione,
insulino resistenza e obesità accelerano tale processo il cui esordio è noto sin dell’età pediatrica ed evolve nel corso
della vita. L’individuazione e la cura dei fattori di rischio cardiovascolari mediante la prevenzione dei fattori causali
ritardano la progressione dell’aterosclerosi e l’insorgenza dei sintomi cardiovascolari. La nutrizione svolge un ruolo
preventivo fondamentale sin dall’epoca prenatale e nelle diverse età della crescita.
La condizione metabolica e neuro-endocrino cui è sottoposto il feto è rilevante per la “programmazione
metabolica”. E’ dimostrata inoltre l’importanza delle modalità di allattamento e divezzamento con particolare
interesse per l’assunzione di proteine nel controllo dei fattori di rischio cardiovascolari. La corretta distribuzione di
macronutrienti (lipidi, proteine e carboidrati) dall’infanzia all’adolescenza favorisce una crescita corretta e risulta utile
a prevenire l’insorgenza dei determinanti di rischio di malattia cardiovascolare in età adulta.
Nella presente review verrà esaminato l’impatto della nutrizione dalle più precoci fasi delle vita sul rischio
cardiovascolare.
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Cardiovascular diseases (CVD) represent the leading
cause of morbidity and mortality in Western countries.
It has been demonstrated that atherosclerosis begins
early in life and progresses throughout life span [1,2].
Risk factors, such as dyslipidemia (including high levels
of low-density lipoprotein cholesterol [LDL-C], high
levels of triglycerides [TG] and low levels of high-
density lipoprotein cholesterol [HDL-C]), hypertension,
obesity, insulin resistance (IR), accelerate the athero-
sclerotic process and increase CVD risk. Several studies
in children and adolescents have demonstrated that risk
factors may be present since childhood, tracking into
adult life, so an early identification is necessary to estab-
lish a primary prevention approach [3]. Recent evidences
from population-based and clinical studies have empha-
sized the importance of primordial prevention, aimed to
avoid risk factors development [3,4].
Several epidemiological studies across a wide range of
countries and ethnicities have demonstrated that nutri-
tion, from fetal life ongoing and early human develop-
ment, exert a profound impact on risk development of
adult disease. The theory of the “fetal origins of adult
disease” (FOAD) [5-7], as coronary artery disease (CAD)
[8], diabetes mellitus (DM) [9], as well as cancer and
others pathologies, was formulated. The FOAD hypoth-
esis is based on the premise of “developmental plasti-
city”: it is the phenomenon by which one genotype can
produce different phenotypes in response to different
environmental factors. In particular there are specific
“critical” periods whereby the organs and systems of the
human body are plastic and sensitive to the environment
[6,10]. During intrauterine life, nutrition plays an im-
portant role for the so called “metabolic programming”:
several different stimuli produce permanent changes
which persist throughout life span and have long-term
implications for later development of metabolic diseases.
This programming extends also into early life and child-
hood [10].
Recent evidences have demonstrated that environ-
mental factors can interact with fetal genome through
epigenetic processes, without altering it. Epigenetic
mechanisms, comprising DNA methylation and de-
methylation, post-transcriptional processes as methyla-
tion, phosphorylation and acetylation of core histones,
produce heritable changes resulting in phenotype varia-
tions [11-13]. These emerging findings can offer oppor-
tunities for novel risk biomarkers and for interventions
to promote health across the life course [11]. Other
mechanisms involved in early life programming are
represented by permanent structural changes (eg, the
permanent reduction of renal glomeruli or β-cell mass in
the endocrine pancreas) and permanent effects on cellu-
lar aging regulation (eg, oxidative stress processes) [14].This review examines the impact of nutrition since
early life on CVD risk.
Prenatal nutrition
Maternal nutritional status influences the quantity and
quality of nutrients reaching the fetus, thus representing
a potential determinant of metabolic programming and
body composition.
Data from several human studies on early-life CVD
risk determinants have been primarily focused on birth-
weight. An inverse association between CVD mortality
and birthweight was identified [5,15,16]. Further epi-
demiological studies have been conducted over the last
decades in attempt to determine a possible correlation
between birthweight and CVD risk factors. Most of
these studies were retrospective and involved adult
populations, while few prospective studies were con-
ducted in children. It has been showed that subjects with
low birthweight (LBW), especially as a result of intra-
uterine growth restriction, presented a higher prevalence
of arterial hypertension [17-19], IR [19], T2DM [9,20]
and metabolic syndrome (MS) [21]. Among birthweight
determinants, the mother size and the intrauterine nutri-
ent supply are the most important. In particular intra-
uterine growth retardation can be induced by prolonged
but modest changes in maternal diet or by more severe
changes in uterine blood supply near to the pregnancy
term.
In relation to nutrients’ quantity, many studies exam-
ined the impact of maternal undernutrition on offspring
phenotype [22,23] and CVD outcome [24,25]. Hales
et al. formulated the hypotheses of “thrifty phenotype”
which suggested that, when exposed to conditions of
deprivation during fetal life, subjects developed meta-
bolic, endocrine and/or anatomical adaptations aimed to
immediate survival [26]. The “thrifty phenotype” is char-
acterized by a condition of IR which may be considered
as the persistence of fetal response in order to facilitate
energy serving and maintain an adequate concentration
of glucose for vital organs, particularly the brain. This
results in a state of hyperglicemia and increases de novo
lipogenesis. The latter is responsible for later disease as
IR and diabetes because of the “mismatch” between
intra- and extra-uterine environment [27,28]. Further it
has been demonstrated that fetal growth restriction
alters adipose tissue development. Subjects born small
for gestational age have greater body fat percentage than
subjects born appropriate for gestational age, and differ-
ence in fat distribution track to adulthood [29].
Furthermore another relevant consequence of under-
nutrition during fetal life is represented by the reduced
cell number and growth in many organs, such as kidney.
A reduced number of glomeruli, associated with the de-
velopment of glomerulo-sclerosis, consequent to an
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of hypertension in adult life [30].
In the last years a dramatic worldwide increase in
overweight and obesity has occurred. This condition of
overnutrition had in turn led to a relevant number of
pregnant women with gestational obesity and gestational
diabetes mellitus thus promoting fetal hyperinsulinemia.
These conditions are related to adulthood overweight,
obesity, impaired glucose tolerance and MS [31,32].
New evidences from epidemiological and experimental
studies have provided data about the impact of maternal
diet quality on long-term implications for their off-
springs thus supporting the concept of gene–diet inter-
actions modulating CVD risk factors. The modulation
by a genetic polymorphism of a dietary component effect
on a specific phenotype (e.g., cholesterol levels and obes-
ity), can interact increasing the risk for developing
chronic disease. Maternal dietary fat composition is the
most important determinant of the quality of fatty acids
which are transferred across the placenta [33]. Maternal
dietary lipids, including fatty acids, have demonstrated
effects on different tissues and metabolic systems: adi-
pose tissue, muscle, liver, pancreas, intestine and hypo-
thalamic appetite/energy sensing pathways. Dietary fatty
acids composition can regulate gene expression, inter-
cellular communications, metabolic and neuroendocrine
networks [34]. Besides the relevance of nutrition itself
attention should be paid to the concept of gene–diet
interactions and its impact on the clinical outcome. The
modulation by a genetic polymorphism of a dietary com-
ponent effect on a specific phenotype (e.g., cholesterol
levels, obesity, hypertension), can interact increasing the
risk for developing chronic disease. A body of studies
focus on concentrations of specific plasma fatty acids
which may interact with genes and are determined by
both intake and metabolism. An example is represented
by the activity of key enzymes desaturases. The latter are
encoded by genes in the FADs cluster that contribute to
PUFA concentrations. A genome-wide association study
applied to the Italian InCHIANTI population described
strong associations for the FADS1, FADS2, and FASD3
variants and PUFA levels. This study identifies sites at
which the genetic variability in enzymes metabolizing es-
sential fatty acids interacts with diet thus changing
plasma fatty acid concentrations and potentially modu-
lating the genetic risk related to metabolic pathways
[35]. Anyway, despite the fact that multiple studies have
shown statistically significant interactions between n-3
fatty acids and genetic variants on intermediate and dis-
ease phenotypes, the individual level of evidence is very
low and recommendations cannot be made on increas-
ing or reducing the intake of n-3 fatty acids based on
each individual’s genotype [36]. In the last half-century
changes in dietary lipid intake are represented by anexcess of ω-6 fatty acids (eg. linoleic acid [LA], arachi-
donic acid [ARA]), inadequate ω-3 fatty acids (including
linolenic acid [ALA], docosahexaenoic acid [DHA] and
eicosapentaenoic acid [EPA]) and monounsaturated oleic
acid consumption, and high intake of fat from refined
triacylglycerols [34]. LA and ALA are mainly derived
from vegetable fats and oils while ARA, DHA and EPA
are present only in animal tissue lipids, thus meaning
that their intake depends mainly on protein dietary
sources. Among fatty acids, the role of DHA with regard
to brain and retina development is well known [37]. Be-
side this property, Weisenger et al. highlighted the pos-
sible effect of DHA on blood pressure (BP) control
because they observed that DHA deficiency in the peri-
natal period resulted in increased BP later in life [38]. So
these results suggest that perinatal supplementation of
long chain polyunsaturated fatty acids (LCPUFA) could
prevent hypertension in adulthood [39].
Heerwagen et al. have suggested that maternal-to-fetal
fatty acid transfer depends on elevated maternal body
and plasma TG concentration producing increased
birthweight, body fat composition and elevated inflam-
matory cytokines [40]. Oxidative stress and inflamma-
tion are particularly influenced by trans fatty acids
derived from partially hydrogenated vegetable oils. These
conditions during fetal life predispose to hyperphagia,
obesity, IR and diabetes [40].
The effects of protein and carbohydrate intake during
pregnancy on offspring long-term health were examined
by observational studies, with contrasting results con-
cerning BP [41-44].
Finally it should be mentioned that air and food pollu-
tants may impact on fetal development as demonstrated
benzopyrene exposure that may impair fetal growth, par-
ticularly in genetically susceptible populations carrying
the variant Val allele on the GSTP1 gene [45].
Breastfeeding
Several studies and statements have demonstrated
the potential benefits of breastfeeding on CVD risk
reduction.
Human milk is a complex fluid secreted by the mam-
mary gland, containing carbohydrates and salts in solu-
tion, casein in colloidal dispersion, cells and cellular
debris, and lipids mostly in emulsified globules [46]. In
addition human milk contains essential fatty acids, hor-
mones, growth factors, immune-related components,
enzymes, polyamines and other biologically active com-
pounds, which may play a relevant role in the health
benefits associated with breastfeeding [47].
Concerning human milk lipids (which content is
around 50%), they are represented by triacylglycerols
(98%), phospholipids (0.8%), cholesterol (0.5%) and many
others. The major monounsaturated fatty acid (MUFA),
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source and structural components, facilitates triacylgly-
cerols metabolism of milk fat globules. Nowadays fatty
acids trans-isomers represent a hot topic: they originate
from the maternal diet, are secreted into human milk
and exert damaging effects on infant development, as
previous reported by Carlson et al. [48].
Exclusive breastfeeding for at least 6 months has been
recommended by the European Society of Pediatric
Gastroenterology Hepatology and Nutrition (ESPGHAN)
because human milk properties are important in promot-
ing optimal growth, neurocognitive development, resist-
ance to infections and cardiovascular health [47,49,50].
Several studies have reported beneficial effects on dyslipi-
demia, hypertension, reduced glucose tolerance, over-
weight/obesity prevention.
Data accumulated over the last years have suggested
that breastfeeding influences lipid metabolism, determin-
ing lower levels of total cholesterol (TC) in adulthood.
Owen et al. in a systematic review observed higher
TC concentrations in breast-fed than in formula-fed
infants (<12 months), because of an higher cholesterol
content in human milk than in infant formulae (mean
TC difference 0.64, 95% CI 0.50 to 0.79 mmol/L), while
adulthood TC levels resulted lower in those breast-fed in
infancy (mean TC difference −0.18, 95% CI −0.30 to
−0.06 mmol/L) [48]. These data were further confirmed
by a meta-analysis conducted by the World Health
Organization (WHO) [51].
These results suggest a possible effect of breast milk
on lipid metabolism by a “nutritional programming”
consequent to an early exposure to human milk high
cholesterol content. This stimulus may modulate choles-
terol metabolism by regulating hydroxymethylglutaril
coenzyme A (HMG-CoA) reductase activity or by in-
creasing LDL-receptor activity [52].
The impact of breastfeeding on BP is controversial. In
a meta-analysis by Owen et al. [53] a slight mean differ-
ence in systolic BP (SBP) of −1.10 mmHg (95% CI −1.79
to −0.42) was found in subjects breast-fed while no dif-
ference was observed for diastolic BP (DBP) later in life.
A subsequent meta-analysis in 2005, including approxi-
mately 10.000 subjects from 3 studies, demonstrated a
difference in SBP of −1.4 mmHg (95% CI −2.2 to −0.6)
and in DBP of −0.5 mmHg (95% CI −0.9 to −0.04) in
adults previously breast-fed [54]. These data were con-
firmed by a meta-analysis conducted by WHO [51].
Martin et al. reported that breastfeeding was associated
with a lower BP at the age of 7.5 years in children born
at term [55], but contrasted with PROBIT study results
which did not demonstrate any effect of breastfeeding
on BP in children 6.5 years aged [56]. Further a negative
association between breastfeeding duration and later BP
was observed [55,57].A possible explanation of the role of human milk in
reducing BP is represented by the low sodium content
[57,58] associated with the LCPUFA high concentration.
LCPUFA are incorporated into cell membranes of the
vascular endothelium and increase endothelial nitric
oxide synthesis [59]. Further it has been demonstrated
that the dietary supplementation with LCPUFA, from
birth to 6 months, is associated with a significant reduc-
tion in mean BP and DBP at the age of 6 years [60]. An-
other possible relevant effect can be exerted by human
milk lower protein amount compared to infant formulae.
The latter higher protein intake could stimulate insulin
secretion, thus promoting IR which in turn may increase
BP via several mechanisms as stimulation of the sympa-
thetic nervous system, smooth muscle hypertrophy and
increased renal sodium retention [61].
A protective role of breastfeeding against glucose in-
tolerance and T2DM development has been demon-
strated in several studies. Owen et al. highlighted, in
a review including results from 7 studies, the possible
preventive effect of breastfeeding on T2DM develop-
ment (OR 0.61, 95% CI 0.41-0.85). These results evi-
denced lower blood glucose and serum insulin levels in
infancy and lower insulin levels later in life [62]. Similar
results were also reported in the WHO meta-analysis
[51]. These effects can be attributed to human milk
components, in particular to hormones such as leptin,
adiponectin, resistin and ghrelin [63]. Considering leptin,
it plays a fundamental role in glucose metabolism
regulation since early life. This hormone, particularly,
improves insulin sensitivity by reducing intracellular
lipid levels in liver, skeletal muscle and pancreatic β-cells
[64]. Also adiponectin contributes to regulate glucose
homeostasis: it increases insulin action in the liver as
well as glucose metabolism in the skeletal muscle [65]. It
should be remarked that adiponectin correlates with
neonatal growth parameters and adiposity. Further resis-
tin shows a role in maintaining metabolic neonatal
homeostasis and it may exert little or no contribution to
IR [66]. Considering ghrelin, there are contrasting data
about its influence on insulin secretion [63].
Breastfeeding could play a key role in preventing over-
weight/obesity across the life course as reported by nu-
merous systematic reviews and reports [67-71]. But how
breastfeeding exert these effects? Breastfeeding potential
benefits on body composition may be due to the slower
pattern of growth, in particular related to the weight
gain, in breastfed compared with formula-fed infants
[72], so the former show a lower risk of obesity. These
outcome difference could be explained by human and
formula milk composition and by infants’ nutritional
behaviour.
About formula and human milk composition, the lat-
ter has a lower protein and a slightly lower energy
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take in infancy enhances the secretion of insulin and in-
sulin growth factor 1 (IGF-1) thus stimulating cell
proliferation, accelerating growth and increasing adipose
tissue deposition, with an early occurrence of adiposity
rebound [73]. These evidences have been confirmed in a
randomized clinical trial, by Koletzko et al., who found a
positive association between infant formula protein con-
tent and higher weight gain in the first 2 years of life
[74]. Further in recent years it has been better under-
stood the role of breast milk hormones on obesity pre-
vention: leptin, adiponectin, IGF-1, ghrelin, obestatin
and resistin regulate energy balance and food intake and
modulate neuroendocrine mechanism involved in body
weight regulation [75].
From a behavioural point of view a possible explan-
ation could be the self regulation achieved by breast-fed
babies that persist later in life [47].
Introduction of complementary foods
Recommendations by ESPGHAN Committee on Nutri-
tion have suggested that exclusive breastfeeding should
be pursued for around 6 months to achieve optimal
growth, development and health [47] and complemen-
tary foods could be introduced between 17 and 26 weeks
[76]. At this time human milk would be insufficient to
satisfy energy, protein, some fat-soluble vitamins and
micronutrients requirements. Among weaning timing
determinants, it has been observed that infant weight
plays an important role as heavier infants tended to be
weaned earlier than age-matched lighter infants [77].
About the relationship between new food introduction
and infant growth, Wilson et al. demonstrated a higher
prevalence of obese children at 7 years of age among
those who were given solid food before 12 weeks of age
[57].
Several studies evaluated the relationship between pro-
tein intake from complementary foods and obesity risk.
Some data have demonstrated that a protein intake of
4–5 g/kg wt per day (corresponding to 16-20% of total
energy intake) at the age of 8–24 months is associated
to an overweight higher risk later in life [78]. This asso-
ciation was not observed when a dietary protein intake
was limited to 3.75 g/kg wt per day (corresponding to
15% of total energy intake) [73]. The association between
high-protein intake and early adiposity rebound has been
explained by Agostoni et al. and Ketelslegers et al.: diet-
ary protein could stimulate the activity of IGF-1, deter-
mining both adipocyte differentiation and adipogenesis
[73,79]. About the relationship between protein intake
during the complementary period and BP, no definitive
conclusions are available at present. Infancy may be a
greater salt sensitive period than later life [80] and it has
been demonstrated that an excess of dietary sodiumintake in newborns and young infants could raise BP
[81] while a salt restriction during the first year of life
significantly slows down the BP rise in childhood [82].
Furthermore the effect of LCPUFA intake during the
complementary feeding period on later BP was consid-
ered by a trial in which 9-month-old infants were ran-
domized to receive a fish oil supplement for 3 months
or no supplement [83]. At 12 months a lower SBP
(−6 mmHg) was reported in those children who received
fish oil supplementation. These results are in accordance
with the follow-up study by Forsyth et al. [60].
Concerning the fat intake during the weaning period,
several studies did not found any association with subse-
quent weight or fatness in infants and children [84,85].
In the DONALD Study Karaolis et al. demonstrated
that, among normal growers, a high fat intake at both 12
and 18–24 months resulted in a normal decrease in
body fat composition between 2 and 5 years, on the con-
trary to rapid growers [84]. Further a significant associ-
ation between fat intake and subsequent weight and
body fat mass was observed after 2 years of age. So these
evidences suggest that fat intake should not be restricted
during the first 2 years of life, except for rare lipid disor-
ders which require fat restriction since early infancy.
The ESPGHAN Committee on Nutrition has recom-
mended that fat content should provide at least 25% of
the total energy intake in order to guarantee a correct
growth and neurocognitive development [76]. It has
been demonstrated that overconsumption of energy-
dense complementary foods could induce excessive
weight gain in infancy, with an higher risk of obesity in
childhood and adulthood [86,87].So the quantity and the
quality of foods given during the weaning period are
fundamental, in particular as feeding practices during
the first year of life provide the basis for food habits in
childhood and impact on later health in adulthood.
Nutrition in childhood and adolescence
Nutrition in childhood and adolescence may play a rele-
vant role in the development of CVD in adulthood. The
National Cholesterol Education Program Pediatric Panel
Report provided dietary recommendations for all chil-
dren as part of a population-based approach to reduce
CVD risk for the first time in 1992 [88]. These recom-
mendations were revised in 1998 [89] and 2008 [90]. In
addition in 2011 the Expert Panel on Integrated Guide-
lines for Cardiovascular Health and Risk Reduction in
Children and Adolescents published a Summary Report
which provided evidences regarding the efficacy of spe-
cific dietary intervention to reduce CVD risk [3].
It has been suggested that the total fat intake should
be limited to 30% of daily calories, saturated fat intake
limited to 7-10% of calories and dietary cholesterol lim-
ited to 200–300 mg/day. The remaining fat intake
Guardamagna et al. Italian Journal of Pediatrics 2012, 38:73 Page 6 of 10
http://www.ijponline.net/content/38/1/73should derived from MUFA (10%) and polyunsaturated
fatty acids (PUFA) (10%); further trans fatty acids should
be avoided. Protein and carbohydrate intakes should ac-
count for 15-20% and 50-55% of daily calories, respect-
ively. These dietary indications, concerning in particular
daily fat intake, are recommended for children older
than 2 years [88].
In the prospective Special Turku Coronary Risk Factor
Intervention Project (STRIP), over than 1.000 infants 7
months aged, recruited from the general population,
were randomized to receive a low-saturated-fat, low-
cholesterol diet (total fat of 30-35% of calories, saturated
fat/MUFA+PUFA ratio of 1:2 and cholesterol intake <
200 mg/day) or an unrestricted diet [91]. These subjects
were followed up during childhood and adolescence, and
parameters including dietary intakes, serum lipids, BP,
somatic growth and sexual maturation were monitored.
It was demonstrated that intervention boy group had
lower cholesterol values than controls between 13 and
60 months of age, while a slightly but no significant dif-
ference was found in females. TG concentration instead
was similar in the 2 groups [92]. The difference in TC
levels was further confirmed in boys at the age of 7
years, together with slightly larger LDL particles in the
intervention group [93], and persisted through at least
the first 14 years of life [94]. The effect on LDL particles
should be underlined because large LDL are demon-
strated to be less atherogenic than small dense LDL. An-
other significant observation was represented by a lower
prevalence of obesity in girls in the intervention group,
compared with controls [95].
In the STRIP study follow-up Niinikoski et al. reported
the positive effect of the restriction of saturated fat from
infancy until 15 years of age on BP. SBP and DBP
resulted 1.0 mm Hg lower (95% CI for systolic: -1.7 to
−0.2; 95% CI for diastolic: -1.5 to −0.4) in children re-
ceiving low-saturated-fat counselling than in control
children [96]. The explanation of these BP variations in
the intervention group can be partly attributed to the
quality of fats assumed, rather than the quantity, as satu-
rated fat intake can determine central obesity, related to
insulin sensitivity. The latter resulted improved during
the intervention period, thus contributing to lower BP
[97]. Other variables such as a higher intake of PUFA, a
higher protein intake, fibers amount, or a combination
of all of these, can exert a significant effect on BP. Over-
all it should be underlined that STRIP supervised dietary
regimen reduces the exposure to cardiovascular risks
without any adverse effects on growth, cognitive and pu-
bertal development.
The relationship between BP and dietary macronutri-
ents in children have been estimated by other studies,
with contrasting findings. Boulton J. observed that
greater intakes of energy, fats, and carbohydrates wereassociated with lower BP in 2 years old children while
no any association with protein intake was detected [98].
On the contrary, Ulbak et al. did not found any associ-
ation between BP and intakes of fats, saturated fatty
acids, PUFA, while a negative association between
MUFA intake (daily energy percentage and g per day)
and SBP was reported. This study also demonstrated
that protein intake, expressed as daily energy percentage
and as g per day, was significantly associated with lower
SBP and DBP in 2.5 years old children [99]. Concerning
gender, Jenner DA et al. observed in 9 years old Australian
children that SBP was negatively associated to calorie-
adjusted protein intake in girls, while no detectable rela-
tionships between BP and calorie-adjusted intakes of fats,
carbohydrates, sodium, potassium, calcium, magnesium
was reported [100]. The possible effect of protein on BP
could be explained by the vasodilating properties of certain
amino acids, which determine an increased production of
nitric oxide [101]. Fiber intake might also influence chil-
dren’s BP [99,102].
It has been reported by many studies that BP tracks
from early childhood into adulthood [103]. Recent data
from the Cardiovascular Risk in Young Finns Study have
been published about the relationship between child-
hood diet, with particular regard to fatty acids quality,
and BP in adulthood in more than 800 individuals who
participate in the 27 years follow-up. Kaikkonen et al.
have highlighted the positive independent association
between childhood serum cholesterol ester fatty acid
(CEFA) proportion and SBP and DBP in adolescence
and adulthood [104]. These results were stronger in men
than in women and stronger for SBP than for DBP. In
particular fatty acids derived from animal fats of dietary
origin seemed to be linked with higher BP in adulthood,
while fatty acids derived from vegetable oils and margar-
ine appeared to be associated with lower BP. Looking at
fatty acids fractions, in men the proportions of saturated
fatty acids, MUFA and ω-3 PUFA were positively asso-
ciated with BP while ω-6 PUFA were negatively asso-
ciated with BP. In women weaker associations between
CEFA proportions and BP were reported.
A dietary intervention is mandatory when CVD risk
factors are present since childhood. The Dietary Inter-
vention Study in Children (DISC) evaluated the effect of
a restricted saturated fat and cholesterol diet in a cohort
of 663 children affected by elevated LDL-C levels, aged 8
to 11 years, with a mean of 7.5 years follow up [105]. It
was found that the dietary intervention could improve
lipid profile over 3 years with intensive adherence, al-
though not significantly over 5 years, probably as a con-
sequence of a lower-intensity maintenance intervention.
In the DISC study the relationship between dietary
nutrients and BP was also investigated [106]. Controlling
for all nutrients, total fats were significantly directly
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cantly inversely associated with DBP. So these results
provide evidence of the potential role of dietary fats, and
possibly fiber, on BP levels in children. Further studies
are required to provide conclusive findings.
Other dietary measures useful for CVD prevention
such as to encourage high dietary fiber intake from food,
to avoid sugar-sweetened beverage intake, and to limit
sodium intake were suggested by the Expert Panel [3].
Dietary fiber is an important constituent of diet: it pro-
motes gastrointestinal function and helps to prevent
CVD risk factors by lowering serum total and LDL-C
[107] and serum insulin concentrations and by reducing
the risk of obesity as demonstrated in young adults
[108]. Dietary fiber intake is inversely associated with en-
ergy density and with increased levels of body fat and is
positively associated with nutrient density. A daily diet-
ary fiber intake of at least age plus 5 g for young chil-
dren up to 14 g/1.000 kcal for older children and
adolescents is recommended.
Several evidences have demonstrated that high added
sugar consumption, in particular in the form of sugar-
sweetened beverages, is associated with cardiovascular
risk factors, both independently and through the devel-
opment of obesity [109,110].
A healthy dietary model widely recognized is repre-
sented by the Mediterranean diet. The beneficial effects
of this food intake regimen on CVD and other major
chronic diseases have been demonstrated by several
studies in different populations, in epidemiological,
population based and randomised clinical trials [111-113].
The traditional components of this dietary pattern are
represented by whole cereals (complex carbohydrates),
vegetables and fruits (fiber, vitamins, antioxidants), nuts
(PUFA), legumes (vegetal proteins), fish (proteins and
PUFA) and virgin olive oil (MUFA and antioxidants).
Serra-Majem et al. demonstrated in a cohort of more than
3.000 Spanish subjects, aged 6–24 years, the high nutri-
tional quality of the Mediterranean diet, particularly in
children and adolescents [114]. In a recent meta-analysis
by Nordmann et al. considering overweight/obese adults
with at least one additional cardiovascular risk factor, the
Mediterranean diet appeared to be more effective than
low-fat diets in inducing clinically relevant long-term
changes in CVD risk factors and inflammatory markers
[115]. Thus this dietary pattern should be promoted since
childhood and adolescence in order to prevent CVD later
in life.Conclusions
This review highlights several evidences from epidemio-
logical, population based and randomized clinical trials
taking in account the nutrition impact on CVD burden.Maternal nutritional status represents a potential de-
terminant of metabolic programming and body compos-
ition affecting fetal life ongoing. This programming
extends also into infancy and childhood: the quantity of
energy intake and particularly the quality of macronutri-
ents influence growth and CVD risk factor development.
Finally this relevant body of knowledge should be con-
sidered in the clinical practice, since prenatal life, in
order to develop preventive and intervention strategies
to promote health across life course, aimed to CVD
prevention.
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